We are live on ! Find out more
MAM

MPM Asset Management Portfolio holdings

AUM $44.5M
1-Year Est. Return 47.28%
This Fund
S&P 500
This Quarter Est. Return
-7.32%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$124M
AUM Growth
-$20.9M
Cap. Flow
-$2.47M
Cap. Flow %
-1.99%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
2
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
RPTX
Repare Therapeutics
RPTX
+$1.66M
2
TRDA icon
Entrada Therapeutics
TRDA
+$810K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRDA icon
1
Entrada Therapeutics
TRDA
$278M
$75.7M 60.89%
4,381,062
-44,722
-1% -$810K
ITOS
2
DELISTED
iTeos Therapeutics
ITOS
$21M 16.91%
2,738,785
DYN icon
3
Dyne Therapeutics
DYN
$4.53B
$16.1M 12.92%
682,376
HOWL icon
4
Werewolf Therapeutics
HOWL
$47M
$6.34M 5.1%
4,284,172
ADAP
5
DELISTED
Adaptimmune Therapeutics
ADAP
$2.99M 2.41%
5,555,461
RPTX
6
DELISTED
Repare Therapeutics
RPTX
$2.21M 1.77%
1,683,707
-558,929
-25% -$1.66M

Similar funds

MPM Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, MPM Asset Management held 6 positions worth $124M, down 14% from $145M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 0%. MPM Asset Management opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • MPM Asset Management's biggest Q4 2024 reduction was Repare Therapeutics, cutting an estimated $1.66M.
  • MPM Asset Management's ten largest holdings make up 100% of its $124M portfolio in Q4 2024.
  • MPM Asset Management opened 0 new positions and closed 0 in Q4 2024.
  • MPM Asset Management's portfolio value fell 14% quarter-over-quarter to $124M.

Based on MPM Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.